ANGELA DAVIS: Open Payments
NPI 1851768352 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 38 payments from 10 companies in 2025. Trend: 2023 $230 · 2024 $567 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $214 |
| Novo Nordisk Inc | 9 | $170 |
| Amgen Inc. | 6 | $112 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| Exact Sciences Corporation | 3 | $49 |
| SHIELD THERAPEUTICS INC | 1 | $26 |
| Almatica Pharma LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: QULIPTA, Ozempic, AIRSUPRA, UBRELVY, Cologuard Collection Kit, VRAYLAR, REPATHA, Rybelsus.
Industry payments across NC — which companies pay providers there.
